Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo R Bartoli

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Annals of Cardiothoracic Surgery|June 23, 2021
Pathologic von Willebrand factor degradation is a major contributor to left ventricular assist device-associated bleeding: pathophysiology and evolving clinical managementCarlo R Bartoli
The Journal of Thoracic and Cardiovascular Surgery|August 15, 2015
Do patients with a continuous-flow left ventricular assist device benefit from induced-pulsatility or are we just spinning our wheels?Carlo R Bartoli, Pavan Atluri
Cardiology Clinics|November 9, 2011
The future of adult cardiac assist devices: novel systems and mechanical circulatory support strategiesCarlo R Bartoli, Robert D Dowling
The Journal of Surgical Research|July 25, 2009
Blood flow in the foreign-body capsules surrounding surgically implanted subcutaneous devicesCarlo R Bartoli, John J Godleski
Journal of Cardiac Surgery|July 12, 2020
Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD managementCarlo R Bartoli, Jooeun Kang, Tadashi Motomura
Biorxiv : the Preprint Server for Biology|June 29, 2026
AZD5069 Inhibits Angiogenesis Without Cytotoxicity In Human Endothelial Cell CultureCarlo R Bartoli, Autumn Anthony, Rohini Desetty
Journal of Cardiac Surgery|November 26, 2013
Diagnosis, nonsurgical management, and prevention of LVAD thrombosisCarlo R Bartoli, Gorav Ailawadi, John A Kern
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 27, 2013
Mechanistic pathway(s) of acquired von willebrand syndrome with a continuous-flow ventricular assist device: in vitro findingsSujith Dassanayaka, Mark S Slaughter, Carlo R Bartoli
Journal of Cardiac Surgery|August 6, 2013
Increased intrathoracic impedance may predict adverse events in LVAD patientsCarlo R Bartoli, Kimberly M Vessels, Kelly C McCants
Annals of Cardiothoracic Surgery|April 12, 2021
Reinventing the displacement left ventricular assist device in the continuous-flow era: TORVAD, the first toroidal-flow left ventricular assist deviceCarlo R Bartoli, Jeffrey R Gohean, Richard W Smalling
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Annals of Cardiothoracic Surgery|June 23, 2021
Pathologic von Willebrand factor degradation is a major contributor to left ventricular assist device-associated bleeding: pathophysiology and evolving clinical managementCarlo R Bartoli
The Journal of Thoracic and Cardiovascular Surgery|August 15, 2015
Do patients with a continuous-flow left ventricular assist device benefit from induced-pulsatility or are we just spinning our wheels?Carlo R Bartoli, Pavan Atluri
Cardiology Clinics|November 9, 2011
The future of adult cardiac assist devices: novel systems and mechanical circulatory support strategiesCarlo R Bartoli, Robert D Dowling
The Journal of Surgical Research|July 25, 2009
Blood flow in the foreign-body capsules surrounding surgically implanted subcutaneous devicesCarlo R Bartoli, John J Godleski
Journal of Cardiac Surgery|July 12, 2020
Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD managementCarlo R Bartoli, Jooeun Kang, Tadashi Motomura
Biorxiv : the Preprint Server for Biology|June 29, 2026
AZD5069 Inhibits Angiogenesis Without Cytotoxicity In Human Endothelial Cell CultureCarlo R Bartoli, Autumn Anthony, Rohini Desetty
Journal of Cardiac Surgery|November 26, 2013
Diagnosis, nonsurgical management, and prevention of LVAD thrombosisCarlo R Bartoli, Gorav Ailawadi, John A Kern
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 27, 2013
Mechanistic pathway(s) of acquired von willebrand syndrome with a continuous-flow ventricular assist device: in vitro findingsSujith Dassanayaka, Mark S Slaughter, Carlo R Bartoli
Journal of Cardiac Surgery|August 6, 2013
Increased intrathoracic impedance may predict adverse events in LVAD patientsCarlo R Bartoli, Kimberly M Vessels, Kelly C McCants
Annals of Cardiothoracic Surgery|April 12, 2021
Reinventing the displacement left ventricular assist device in the continuous-flow era: TORVAD, the first toroidal-flow left ventricular assist deviceCarlo R Bartoli, Jeffrey R Gohean, Richard W Smalling
Pageof 7